medullary thyroid cancer and glp 1 Does Using GLP-1 Drugs, Like Zepbound or Wegovy, Increase Your Risk of Cancer? GLP-1 receptor agonist use for

The manufacturers in animal studies have said that there could be adverse outcomes

In these studies, insulin was discontinued, and patients were started on liraglutide at a low dose, which was subsequently titrated based on tolerance and need

The medication has a long half-life of approximately one week, allowing for convenient once-weekly dosing of the injectable formulations

Pros : Cons : What your doctor might consider Wegovy (semaglutide) is another FDA-approved option for weight managementonce-weekly instead of daily

This is different from type 1 diabetes, in which the body does not produce insulin at all, and individuals must rely on daily synthetic insulin injections to survive

This significant weight loss can lead to improved health outcomes, including reduced risk of cardiovascular diseases and better management of blood sugar levels